These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15012931)

  • 1. Anti-cytokine Ab immune therapy: present status and perspectives.
    Zagury D; Gallo RC
    Drug Discov Today; 2004 Jan; 9(2):72-81. PubMed ID: 15012931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-toxic immunogens for therapeutic anticytokine vaccines.
    Zagury D; Le Buanec H; Bizzini B; Gallo RC
    IDrugs; 2001 Oct; 4(10):1161-6. PubMed ID: 15957085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active and passive anticytokine immune therapies: current status and development.
    Le Buanec H; Bensussan A; Bagot M; Gallo RC; Zagury D
    Adv Immunol; 2012; 115():187-227. PubMed ID: 22608260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection.
    Capini CJ; Bertin-Maghit SM; Bessis N; Haumont PM; Bernier EM; Muel EG; Laborie MA; Autin L; Paturance S; Chomilier J; Boissier MC; Briand JP; Muller S; Cavaillon JM; Therwath A; Zagury JF
    Vaccine; 2004 Aug; 22(23-24):3144-53. PubMed ID: 15297067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-cytokine therapy: present status and future perspectives in nephrology].
    Panichi V; Paoletti S
    G Ital Nefrol; 2004; 21(5):446-53. PubMed ID: 15547876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases.
    Zagury D; Le Buanec H; Bizzini B; Burny A; Lewis G; Gallo RC
    Cytokine Growth Factor Rev; 2003 Apr; 14(2):123-37. PubMed ID: 12651224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer immunotherapy of targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies.
    Svenson M; Geborek P; Saxne T; Bendtzen K
    Rheumatology (Oxford); 2007 Dec; 46(12):1828-34. PubMed ID: 18032541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-based therapy and biochemotherapy for advanced melanoma.
    Atkins MB
    Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2353s-2358s. PubMed ID: 16609058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of antibodies in the treatment of infectious diseases.
    Chan CE; Chan AH; Hanson BJ; Ooi EE
    Singapore Med J; 2009 Jul; 50(7):663-72; quiz 673. PubMed ID: 19644620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases.
    Calcagni E; Elenkov I
    Ann N Y Acad Sci; 2006 Jun; 1069():62-76. PubMed ID: 16855135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune therapies of autoimmune diseases: are we approaching a real cure?
    Chatenoud L
    Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer.
    Bizzini B; Drouet B; Zagury D; Abitbol M; Burny A; Boissier MC
    Immunotherapy; 2010 May; 2(3):347-65. PubMed ID: 20635900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cytokine vaccination: a new biotherapy of autoimmunity?
    Semerano L; Assier E; Boissier MC
    Autoimmun Rev; 2012 Sep; 11(11):785-6. PubMed ID: 22349621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.